Renowned luminaries in Personalized Medicine
Groundbreaking companies with emerging technologies
More than 1000 peers from around the globe
50 sessions in 3 parallel tracks


Expediting Genomics into the Clinic

The widespread clinical application of personalized genomic medicine has historically been hampered by several important factors, including data interpretation, the high cost of testing, and the extended turnaround times associated with in-depth genomic analysis. Expediting these technologies into clinical practice for the benefit of patients is the topic of this session. Panelists will discuss the clinical applications of genomic medicine and share insights regarding the barriers and opportunities to moving genomics into regular clinical practice.


Lincoln Nadauld, M.D., Director of Cancer Genomics, Intermountain Healthcare

Dr. Lincoln Nadauld, MD/PhD, was most recently hired to head the new cancer genomics department at Intermountain Healthcare’s first in-house cancer genomic program. Dr. Nadauld attended Brigham Young University for his undergraduate degree and went on to complete medical and doctoral degrees (MD/PhD) followed by internship and residency at the University of Utah. Read Full Bio

Edgar D. Staren, M.D., Ph.D., MBA, President, Advanced Individual Medicine (AIM)

Edgar Staren serves as CEO of Ashion PMed Management, LLC and President of Ashion Advanced Individual Medicine®, LLC (AIM). He received his Medical Degree from Loyola, his surgical training at Rush University Medical Center and completed his surgical oncology fellowship at Rush and Cook County Hospitals. Read Full Bio

James M. Ford, M.D., Associate Professor of Medicine and Genetics, Stanford University School of Medicine

Dr. Ford’s overall research goals are to understand the role of genetic changes in cancer genes in the risk and development of solid tumors. The laboratory focuses on how DNA repair and DNA damage response pathways are critical to tumorigenesis and are potential candidates for targeted therapeutics and prevention. Read Full Bio

Web Analytics